Silverarc Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $926K | Buy |
|
|||||
|
2025
Q1 | $1.06M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $3M | Sell |
|
|||||
|
2024
Q2 | $5.03M | Sell |
|
|||||
|
2024
Q1 | $13.3M | Sell |
|
|||||
|
2023
Q4 | $14.9M | Buy |
|
|||||
|
2023
Q3 | $6.35M | Buy |
|
|||||
|
2023
Q2 | $3.29M | Buy |
|
|||||
|
2023
Q1 | $2.22M | Sell |
|
|||||
|
2022
Q4 | $6.68M | Buy |
|
|||||
|
2022
Q3 | $6.72M | Buy |
|
|||||
|
2022
Q2 | $3.93M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $1.7K | Buy |
|
|||||
|
2021
Q1 | $405K | Buy |
|
|||||
|
2020
Q4 | $286K | Buy |
|